Biomerica Revenue, Profits - BMRA Quarterly Income Statement

Add to My Stocks
$3.37 $0.02 (0.59%) BMRA stock closing price Sep 19, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Biomerica stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for BMRA which shows a YOY revenue decline of -18.12% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Biomerica assets and Biomerica free cash flow, Biomerica profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q4 is $-0.67M and the 2018 Q4 revenue is $1.13M.

View and download details of revenue and profits for Biomerica for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jun - May2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Biomerica Revenues or Net Sales
1.13M1.38M1.61M1.45M1.45M1.5M1.43M1.41M1.33M1.36M
Cost Of Goods Sold (COGS)--1.1M-1.01M1.05M---1.01M
Biomerica Gross Profit
----------
Research & Development Expense----------
Selling General & Admin Expense----------
Income Before Depreciation Depletion Amortization-0.64M-0.32M-0.28M-0.22M-0.37M-0.31M-0.21M-0.06M-0.29M-0.26M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
Biomerica Pretax Income
-0.64M-0.32M-0.26M-0.2M-0.35M-0.3M-0.2M-0.05M-0.27M-0.26M
Provision for Income Taxes----------0.12M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-0.67M-0.32M-0.27M-0.21M-0.35M-0.3M-0.2M-0.06M-1.23M-0.14M
Extraordinary Items & Discontinued Operations----------
Biomerica Profit/ Loss (Net Income)
-0.67M-0.32M-0.27M-0.21M-0.35M-0.3M-0.2M-0.06M-1.23M-0.14M
Average Shares used to compute Diluted EPS8.35M8.56M8.52M8.51M8.65M8.43M8.19M8.17M7.66M7.62M
Average Shares used to compute Basic EPS8.35M8.56M8.52M8.51M8.65M8.43M8.19M8.17M7.66M7.62M
Income Before Nonrecurring Items-0.67M-0.32M-0.27M-0.21M-0.35M-0.3M-0.2M-0.06M-1.23M-0.14M
Income from Nonrecurring Items----------
Biomerica Earnings Per Share Basic Net
-0.08-0.04-0.03-0.02-0.04-0.04-0.02-0.01-0.16-0.02
Biomerica Earnings Per Share Diluted Net
-0.08-0.04-0.03-0.02-0.04-0.04-0.02-0.01-0.16-0.02
EPS Diluted Before Nonrecurring Items-0.08-0.04-0.03-0.02-0.04-0.04-0.02-0.01-0.16-0.02
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Biomerica stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $1.13M for this quarter of 2018 Q4. Our Biomerica revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. BMRA stock had a poor bottom line growth.

The income statement is also called statement of revenue and expense. The BMRA financials along with Biomerica historical stock prices provide a lot of details about the firm.

Biomerica Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
5.05
Dividend Yield
0%